Cargando…
A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model
BACKGROUND: Rare disease patient-reported outcome measures (PROMs) require linguistic adaptation to overcome the challenge of geographically dispersed patient populations. Importantly, PROMs such as health-related quality of life (HRQoL) should accurately capture responses to patient-identified conc...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351336/ https://www.ncbi.nlm.nih.gov/pubmed/34372892 http://dx.doi.org/10.1186/s13023-021-01944-9 |
_version_ | 1783735953664245760 |
---|---|
author | Kocher, Agnes Ndosi, Mwidimi Denhaerynck, Kris Simon, Michael Dwyer, Andrew A. Distler, Oliver Hoeper, Kirsten Künzler-Heule, Patrizia Redmond, Anthony C. Villiger, Peter M. Walker, Ulrich A. Nicca, Dunja |
author_facet | Kocher, Agnes Ndosi, Mwidimi Denhaerynck, Kris Simon, Michael Dwyer, Andrew A. Distler, Oliver Hoeper, Kirsten Künzler-Heule, Patrizia Redmond, Anthony C. Villiger, Peter M. Walker, Ulrich A. Nicca, Dunja |
author_sort | Kocher, Agnes |
collection | PubMed |
description | BACKGROUND: Rare disease patient-reported outcome measures (PROMs) require linguistic adaptation to overcome the challenge of geographically dispersed patient populations. Importantly, PROMs such as health-related quality of life (HRQoL) should accurately capture responses to patient-identified concerns. The Systemic Sclerosis Quality of Life Questionnaire (SScQoL) is a 29-item tool validated in six languages. Previous evaluation of the German version revealed problems with dichotomous responses. This study aimed to revise the German SScQoL, extend the response structure, and evaluate content and construct validity, reliability and unidimensionality. METHODS: The instrument validation study involved revising the German SScQoL response structure, cognitive debriefing with patients and validation using Rasch analysis. The revised SScQoL was completed by Swiss-German-speaking patients with SSc within the Swiss MANagement Of Systemic Sclerosis (MANOSS) study. Rasch analysis was employed to test the validity, reliability and unidimensionality of the revised instrument. RESULTS: Based on cognitive debriefing with patients (n = 6) dichotomous items were extended to a polytomous 4-point response structure. A total of 78 patients completed the revised SScQoL. Initial analysis of the 29 items suggested the scale lacked fit to the model (χ(2) = 51.224, df = 29, p = 0.007). Grouping items into five domains resulted in an adequate fit to the Rasch model (χ(2) = 5.343, df = 5, p = 0.376) and unidimensionality (proportion of significant independent t tests: 0.045, 95% CI 0.016–0.114). Overall, the scale was well targeted, had high internal consistency (Person Separation Index, PSI = 0.931) and worked consistently in patients with different demographic and clinical characteristics. CONCLUSIONS: The revised German SScQoL has a 4-point response structure and is a valid, reliable measure. Rasch analysis is useful for validating continuous response structure of quality of life measures. Further evaluation of measurement equivalence with other German-speaking cultures is required for multinational comparisons and data pooling. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-021-01944-9. |
format | Online Article Text |
id | pubmed-8351336 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-83513362021-08-09 A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model Kocher, Agnes Ndosi, Mwidimi Denhaerynck, Kris Simon, Michael Dwyer, Andrew A. Distler, Oliver Hoeper, Kirsten Künzler-Heule, Patrizia Redmond, Anthony C. Villiger, Peter M. Walker, Ulrich A. Nicca, Dunja Orphanet J Rare Dis Research BACKGROUND: Rare disease patient-reported outcome measures (PROMs) require linguistic adaptation to overcome the challenge of geographically dispersed patient populations. Importantly, PROMs such as health-related quality of life (HRQoL) should accurately capture responses to patient-identified concerns. The Systemic Sclerosis Quality of Life Questionnaire (SScQoL) is a 29-item tool validated in six languages. Previous evaluation of the German version revealed problems with dichotomous responses. This study aimed to revise the German SScQoL, extend the response structure, and evaluate content and construct validity, reliability and unidimensionality. METHODS: The instrument validation study involved revising the German SScQoL response structure, cognitive debriefing with patients and validation using Rasch analysis. The revised SScQoL was completed by Swiss-German-speaking patients with SSc within the Swiss MANagement Of Systemic Sclerosis (MANOSS) study. Rasch analysis was employed to test the validity, reliability and unidimensionality of the revised instrument. RESULTS: Based on cognitive debriefing with patients (n = 6) dichotomous items were extended to a polytomous 4-point response structure. A total of 78 patients completed the revised SScQoL. Initial analysis of the 29 items suggested the scale lacked fit to the model (χ(2) = 51.224, df = 29, p = 0.007). Grouping items into five domains resulted in an adequate fit to the Rasch model (χ(2) = 5.343, df = 5, p = 0.376) and unidimensionality (proportion of significant independent t tests: 0.045, 95% CI 0.016–0.114). Overall, the scale was well targeted, had high internal consistency (Person Separation Index, PSI = 0.931) and worked consistently in patients with different demographic and clinical characteristics. CONCLUSIONS: The revised German SScQoL has a 4-point response structure and is a valid, reliable measure. Rasch analysis is useful for validating continuous response structure of quality of life measures. Further evaluation of measurement equivalence with other German-speaking cultures is required for multinational comparisons and data pooling. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-021-01944-9. BioMed Central 2021-08-09 /pmc/articles/PMC8351336/ /pubmed/34372892 http://dx.doi.org/10.1186/s13023-021-01944-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Kocher, Agnes Ndosi, Mwidimi Denhaerynck, Kris Simon, Michael Dwyer, Andrew A. Distler, Oliver Hoeper, Kirsten Künzler-Heule, Patrizia Redmond, Anthony C. Villiger, Peter M. Walker, Ulrich A. Nicca, Dunja A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model |
title | A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model |
title_full | A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model |
title_fullStr | A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model |
title_full_unstemmed | A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model |
title_short | A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model |
title_sort | rare disease patient-reported outcome measure: revision and validation of the german version of the systemic sclerosis quality of life questionnaire (sscqol) using the rasch model |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351336/ https://www.ncbi.nlm.nih.gov/pubmed/34372892 http://dx.doi.org/10.1186/s13023-021-01944-9 |
work_keys_str_mv | AT kocheragnes ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT ndosimwidimi ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT denhaerynckkris ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT simonmichael ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT dwyerandrewa ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT distleroliver ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT hoeperkirsten ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT kunzlerheulepatrizia ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT redmondanthonyc ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT villigerpeterm ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT walkerulricha ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT niccadunja ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT kocheragnes rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT ndosimwidimi rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT denhaerynckkris rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT simonmichael rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT dwyerandrewa rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT distleroliver rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT hoeperkirsten rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT kunzlerheulepatrizia rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT redmondanthonyc rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT villigerpeterm rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT walkerulricha rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT niccadunja rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel |